Portola Pharmaceuticals Inc

Bank of New York Mellon Corp

Report date

6/30/2020

Quarter

2020 Q2

Filed

8/12/2020

Shares

307,215

Value ($000)

5,527

Weight

0.0%

2013 Q4 - 2020 Q2 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q2	8/12/2020	5,527	0.0%	307,215	6/30/2020
2020 Q1	5/6/2020	2,487	0.0%	348,810	3/31/2020
2019 Q4	2/14/2020	7,457	0.0%	312,249	12/31/2019
2014 Q1	5/14/2014	2,659	0.0%	102,661	3/31/2014
2013 Q4	2/12/2014	2,553	0.0%	99,123	12/31/2013